Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine Enhancing Naltrexone in Opioid Addiction
NCT00142909Phase 2Completed
- Sponsor
- Yale University
- Start
- Feb 2005
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lofexidine in opioid use disorder (OUD), sponsored by Yale University. Started Feb 2005; status: completed.
02
Drugs
lofexidine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00142909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142909.